Cargando…

S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN)

Detalles Bibliográficos
Autores principales:	Anderson, Alan, El Rassi, Fuad, Debaun, Michael R., Idowu, Modupe, Kanter, Julie, Adam, Soheir, Curtis, Susanna, Liles, Darla, Andemariam, Biree, Mclemore, Morgan L., Sheppard Nickel, Robert, Ramadas, Poornima, Paulose, Jincy, Laine, Dram, Khan, Mahmudul, Darbari, Deepika, Burnett, Arthur L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428507/ http://dx.doi.org/10.1097/01.HS9.0000967984.54376.db

Ejemplares similares

Successful Treatment of SCD-Related Priapism With Crizanlizumab: A Case Series
por: Idowu, Modupe, et al.
Publicado: (2023)

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2022)

Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high‐ and low‐ to middle‐income countries for the international Sickle Cell World Assessment Survey
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2022)

5610357 REDUCTION IN BLOOD TRANSFUSION BURDEN FOLLOWING INITIATION OF VOXELOTOR OR CRIZANLIZUMAB: A CASE SERIES
por: Baruwa Etti, A., et al.
Publicado: (2023)

Phylarchus and the Spartan revolution
por: Africa, Thomas W.
Publicado: (1961)

Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin’s lymphoma
por: Andemariam, Biree, et al.
Publicado: (2007)

S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD)
por: Kanter, J, et al.
Publicado: (2022)

High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study
por: Kanter, Julie, et al.
Publicado: (2019)

Spartan 3 FPGA Family: Introduction and Ordering Information
por: XILINX. San Jose
Publicado: (2007)

Spartan deficiency causes genomic instability and progeroid phenotypes
por: Maskey, Reeja S., et al.
Publicado: (2014)

Spartan Face Mask Detection and Facial Recognition System
por: Song, Ziwei, et al.
Publicado: (2022)

PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS
por: Abboud, Miguel, et al.
Publicado: (2023)

5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
por: Kanter, J., et al.
Publicado: (2023)

FPGA prototyping by VHDL examples: Xilinx Spartan-3 version
por: Chu, Pong P
Publicado: (2008)

FPGA prototyping by Verilog examples: Xilinx Spartan-3 version
por: Chu, Pong P
Publicado: (2008)

Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?
por: Gue, Ying X., et al.
Publicado: (2021)

Valsartan impedes epinephrine-induced ICAM-4 activation on normal, sickle cell trait and sickle cell disease red blood cells
por: Zhang, Jing, et al.
Publicado: (2019)

Spartan: A Comprehensive Tool for Understanding Uncertainty in Simulations of Biological Systems
por: Alden, Kieran, et al.
Publicado: (2013)

Spartan deficiency causes accumulation of Topoisomerase 1 cleavage complexes and tumorigenesis
por: Maskey, Reeja S., et al.
Publicado: (2017)

Patient Controlled Analgesia for Adults with Sickle Cell Disease Awaiting Admission from the Emergency Department
por: Santos, Josue, et al.
Publicado: (2016)

P1432: PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE
por: Andemariam, Biree, et al.
Publicado: (2023)

Regulation of error-prone translesion synthesis by Spartan/C1orf124
por: Kim, Myoung Shin, et al.
Publicado: (2013)

Correction: Spartan: A Comprehensive Tool for Understanding Uncertainty in Simulations of Biological Systems
por: Alden, Kieran, et al.
Publicado: (2013)

Health Tract, No. 268: Adulterations
Publicado: (1867)

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
por: Rao, Shivani, et al.
Publicado: (2021)

UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease
por: Buka, Richard J, et al.
Publicado: (2022)

Propofol and priapism
por: Senthilkumaran, Subramanian, et al.
Publicado: (2010)

Pregabalin and priapism
por: Ramasamy, Ranjith
Publicado: (2014)

Persistent Priapism
Publicado: (1881)

Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples
por: Davis, Brittney H., et al.
Publicado: (2019)

SPaRTAN, a computational framework for linking cell-surface receptors to transcriptional regulators
por: Ma, Xiaojun, et al.
Publicado: (2021)

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
por: Idris, Ibrahim M., et al.
Publicado: (2022)

S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL
por: Heeney, M, et al.
Publicado: (2022)

Real-World Data of Crizanlizumab in Sickle Cell Disease: A Single-Center Analysis
por: Cheplowitz, Halle, et al.
Publicado: (2023)

Combination High Flow Priapism With Low Flow Priapism: Case Report
por: Carvajal, Alejandro, et al.
Publicado: (2018)

Spartan Caregiver Support: Program Description and Key Findings During Michigan’s Stay-At-Home Order
por: White, Allison N., et al.
Publicado: (2022)

Priapism associated with pregabalin
por: Alsulihem, Ali A., et al.
Publicado: (2014)

A Case of Priapism
por: Boys, A. H.
Publicado: (1883)

Aripiprazole-induced priapism
por: Trivedi, Satya K., et al.
Publicado: (2016)

Advances in the understanding of priapism
por: Hudnall, Matthew, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ki2heglkgc94agebs3v3rhksc9